| Pharmacy | |||||
| Bachelor | TR-NQF-HE: Level 6 | QF-EHEA: First Cycle | EQF-LLL: Level 6 | ||
| Course Code: | ECZ401 | ||||
| Course Name: | Clinical Pharmacy and Pharmaceutical Care | ||||
| Semester: | Fall | ||||
| Course Credits: |
|
||||
| Language of instruction: | Turkish | ||||
| Course Condition: | |||||
| Does the Course Require Work Experience?: | No | ||||
| Type of course: | Compulsory Courses | ||||
| Course Level: |
|
||||
| Mode of Delivery: | E-Learning | ||||
| Course Coordinator: | Prof. Dr. ŞULE APİKOĞLU | ||||
| Course Lecturer(s): | Prof. Dr. Şule Rabuş | ||||
| Course Assistants: |
| Course Objectives: | The aim of this course is to train pharmacists who can identify and solve drug-related problems, who are competent in interpreting laboratory data and in the management of acute and chronic conditions commonly encountered during pharmacy practice. |
| Course Content: | In this course, students will learn and conduct the basic principles of patient-centered pharmacy services such as clinical pharmacy, pharmaceutical care and comprehensive drug management. Alongside these key concepts, students will learn about the clinical pharmacist's approach to the interpretation of laboratory data and the principles of antimicrobial therapy, as well as management strategies for common acute and chronic conditions such as pain, diabetes, hyperlipidemia, ischemic heart disease, urinary tract infections, asthma and COPD. In the application part, the student will apply all these principles to virtual cases and produce solutions to patient problems. |
|
The students who have succeeded in this course;
1) explains the basics of clinical pharmacy. 2) defines the systematic approach to case studies. 3) interprets and evaluates commonly used laboratory test results. 4) describe the principles of antimicrobial therapy and the role of the clinical pharmacist in the management of diseases such as urinary tract infections; and distinguish treatment modalities. 5) describe the essentials of pain, diabetes, hyperlipidemia, ischemic heart disease, asthma and COPD management and the role of the clinical pharmacist; and distinguish treatment modalities |
| Week | Subject | Related Preparation |
| 1) | Introduction to Clinical Pharmacy and Pharmaceutical Care | |
| 2) | Comprehensive Medication Management | |
| 3) | Interpretation of Laboratory Data - 1 | |
| 4) | Interpretation of Laboratory Data - 2 | |
| 5) | Diabetes Management - 1 | |
| 6) | Diabetes Management - 2 | |
| 7) | hyperlipidemia | |
| 8) | Ischemic Heart Disease Management | |
| 9) | Antimicrobial Treatment Principles | |
| 10) | Urinary Tract Infections Management | |
| 11) | Asthma Management | |
| 12) | COPD Management | |
| 13) | Pain Management - 1 | |
| 14) | Pain Management - 2 |
| Course Notes / Textbooks: | Applied Therapeutics. The Clinical Use of Drugs. Mary Anne Koda-Kimble, Lloyd Young. 11th edition 2018, Walters-Kluwer, Washington. Clinical Pharmacy and Therapeutics. Roger Walker, Clive Edwards. 5th edition 2012, Elsevier, UK. Handbook of Institutional Pharmacy Practice, M.C. Smith, T.R. Brown, Williams & Wilkins, 1979, USA Pharmacotherapy. A pathophysiologic Approach. Joseph T. DiPiro, 6th edition 2017, McGraw Hill, USA. |
| References: | Applied Therapeutics. The Clinical Use of Drugs. Mary Anne Koda-Kimble, Lloyd Young. 11th edition 2018, Walters-Kluwer, Washington. Clinical Pharmacy and Therapeutics. Roger Walker, Clive Edwards. 5th edition 2012, Elsevier, UK. Handbook of Institutional Pharmacy Practice, M.C. Smith, T.R. Brown, Williams & Wilkins, 1979, USA Pharmacotherapy. A pathophysiologic Approach. Joseph T. DiPiro, 6th edition 2017, McGraw Hill, USA. |
| Course Learning Outcomes | 1 |
2 |
3 |
4 |
5 |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Program Outcomes | |||||||||||
| 1) Applies and develops the universal and social dimensional effects of basic, professional and technological knowledge in the field of pharmacy as well as pharmacy practice interdisciplinary by following legal, deontological and ethical rules. | 1 | 1 | 1 | 1 | 1 | ||||||
| 2) Defines the terminology related to the pharmacy profession; solves problems , accesses scientific information in the field of pharmacy, after monitoring and evaluating the current literature, applies , communicates, shares by using information technologies effectively and efficiently. | 1 | 1 | 1 | 1 | 1 | ||||||
| 3) Uses theoretical and practical knowledge about the anatomical structure of the human body, the physiological working principles of systems, biochemical, immunological events in the organism and microorganisms. | 2 | 2 | 2 | 2 | 2 | ||||||
| 4) Uses basic and advanced analytical techniques and methods by running qualitative/quantitative analyzes and interprets the findings by using appropriate statistical methods. | |||||||||||
| 5) Defines medicinal plants, herbal drugs and active substances; gains the skills for the development of natural products used for medical purposes. | |||||||||||
| 6) Applies patient-centered and individualized pharmaceutical care service together with other healthcare personnel within the framework of rational drug use by using the principles of clinical pharmacy, pharmacoeconomics, pharmacotherapy and phytotherapy. | 3 | 3 | 3 | 3 | 3 | ||||||
| 7) Knows the biological properties, structure-activity relationships, and metabolisms of drugs and gains the skill for the synthesize and development of new drug candidates. | 2 | 2 | 2 | 2 | 2 | ||||||
| 8) He/She is competent at formulations, production, stability, quality assurance, licensing, patent studies, legal regulations of products containing natural origin and / or synthetic active substances, advanced therapy medicinal products, radiopharmaceuticals and cosmetic products. | 1 | 1 | 1 | 1 | 1 | ||||||
| 9) Interprets the pharmacokinetic and pharmacodynamic properties of drugs, the factors that change their effect, their toxic effects, pharmacolygical activities and their risk assessment method. Reports the drug interactions and adverse drug reactions, monitors and applies the theoretical/practical knowledge for preventing them. | 3 | 3 | 3 | 3 | 3 | ||||||
| 10) As a health professional in his/her profession he/she acts as a caregiver, decision maker, communicator, manager, lifelong learner, instructor, leader and researcher, he/she complies with the principles of evidence-based pharmacy by making teamwork for the benefit of society, national and universal values. | 3 | 3 | 3 | 3 | 3 | ||||||
| 11) He/She works in various fields such as community pharmacy, hospitals, pharmaceutical medical devices, herbal products and cosmetics sectors, health institutions and agencies, clinical research organizations , universities and R&D centers. | 3 | 3 | 3 | 3 | 3 | ||||||
| No Effect | 1 Lowest | 2 Average | 3 Highest |
| Program Outcomes | Level of Contribution | |
| 1) | Applies and develops the universal and social dimensional effects of basic, professional and technological knowledge in the field of pharmacy as well as pharmacy practice interdisciplinary by following legal, deontological and ethical rules. | 1 |
| 2) | Defines the terminology related to the pharmacy profession; solves problems , accesses scientific information in the field of pharmacy, after monitoring and evaluating the current literature, applies , communicates, shares by using information technologies effectively and efficiently. | 1 |
| 3) | Uses theoretical and practical knowledge about the anatomical structure of the human body, the physiological working principles of systems, biochemical, immunological events in the organism and microorganisms. | 2 |
| 4) | Uses basic and advanced analytical techniques and methods by running qualitative/quantitative analyzes and interprets the findings by using appropriate statistical methods. | |
| 5) | Defines medicinal plants, herbal drugs and active substances; gains the skills for the development of natural products used for medical purposes. | |
| 6) | Applies patient-centered and individualized pharmaceutical care service together with other healthcare personnel within the framework of rational drug use by using the principles of clinical pharmacy, pharmacoeconomics, pharmacotherapy and phytotherapy. | 3 |
| 7) | Knows the biological properties, structure-activity relationships, and metabolisms of drugs and gains the skill for the synthesize and development of new drug candidates. | 2 |
| 8) | He/She is competent at formulations, production, stability, quality assurance, licensing, patent studies, legal regulations of products containing natural origin and / or synthetic active substances, advanced therapy medicinal products, radiopharmaceuticals and cosmetic products. | 1 |
| 9) | Interprets the pharmacokinetic and pharmacodynamic properties of drugs, the factors that change their effect, their toxic effects, pharmacolygical activities and their risk assessment method. Reports the drug interactions and adverse drug reactions, monitors and applies the theoretical/practical knowledge for preventing them. | 3 |
| 10) | As a health professional in his/her profession he/she acts as a caregiver, decision maker, communicator, manager, lifelong learner, instructor, leader and researcher, he/she complies with the principles of evidence-based pharmacy by making teamwork for the benefit of society, national and universal values. | 3 |
| 11) | He/She works in various fields such as community pharmacy, hospitals, pharmaceutical medical devices, herbal products and cosmetics sectors, health institutions and agencies, clinical research organizations , universities and R&D centers. | 3 |
| Semester Requirements | Number of Activities | Level of Contribution |
| Midterms | 1 | % 30 |
| Final | 1 | % 70 |
| total | % 100 | |
| PERCENTAGE OF SEMESTER WORK | % 30 | |
| PERCENTAGE OF FINAL WORK | % 70 | |
| total | % 100 | |
| Activities | Number of Activities | Workload |
| Course Hours | 16 | 32 |
| Application | 16 | 32 |
| Study Hours Out of Class | 16 | 16 |
| Midterms | 16 | 16 |
| Final | 16 | 32 |
| Total Workload | 128 | |